Author

P. Authie

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:mouse· 4 Research Focus:cell type annotation· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1 Assay:imaging· 1

Frequent Co-Authors

A. Noirat· 4 shared B. Vesin· 4 shared F. ANNA· 4 shared F. Guinet· 4 shared K. Nemirov· 4 shared L. MAJLESSI· 4 shared M. Bourgine· 4 shared P. Charneau· 4 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

A. Noirat

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Mice Humanized for Major Histocompatibility Complex and Angiotensin-Converting Enzyme 2 with High Permissiveness to SARS-CoV-2 Omicron Replication

F. Le Chevalier, P. Authie, S. Chardenoux, M. Bourgine, B. Vesin, D. Cussigh, Y. Sassier, I. Fert, A. Noirat, K. Nemirov, F. ANNA, M. BERARD, F. Guinet, D. Hardy, P. Charneau, , L. MAJLESSI

This paper develops hACE2 transgenic mice with high permissiveness to SARS-CoV-2 Omicron replication and uses them to test a vaccine candidate.

bioRxiv · Dec 1, 2022 · PreprintMicrobiology

An intranasal lentiviral booster broadens immune recognition of SARS-CoV-2 variants and reinforces the waning mRNA vaccine-induced immunity that it targets to lung mucosa

B. Vesin, J. Lopez, A. Noirat, P. Authie, I. Fert, F. Le Chevalier, F. Moncoq, K. Nemirov, C. Blanc, C. Planchais, H. Mouquet, F. Guinet, D. Hardy, C. Gerke, F. Anna, , P. Charneau

This study shows an intranasal lentiviral booster enhances and broadens immune response to SARS-CoV-2 variants and improves waning mRNA vaccine immunity in the lungs.

bioRxiv · Jan 30, 2022 · PreprintImmunology

Full Brain and Lung Prophylaxis against SARS-CoV-2 by Intranasal Lentiviral Vaccination in a New hACE2 Transgenic Mouse Model or Golden Hamsters

M.-W. Ku, P. Authie, M. Bourgine, F. Anna, A. Noirat, F. Moncoq, B. Vesin, F. Nevo, J. Lopez, P. Souque, C. Blanc, S. Chardenoux, I. Lafosse, D. Hardy, K. Nemirov, , P. Charneau

This study shows that an intranasal lentiviral vaccine protects both the respiratory and central nervous systems against SARS-CoV-2 in a new hACE2 transgenic mouse model.

bioRxiv · Feb 3, 2021 · PreprintMicrobiology

Intranasal Vaccination with a Lentiviral Vector Strongly Protects against SARS-CoV-2 in Mouse and Golden Hamster Preclinical Models

M.-W. Ku, M. Bourgine, P. Authie, J. Lopez, K. Nemirov, F. Moncoq, A. Noirat, B. Vesin, F. Nevo, C. Blanc, P. Souque, H. Tabbal, E. Simon, M. Le Dudal, F. Guinet, , P. Charneau

This study shows that intranasal vaccination with a lentiviral vector encoding the SARS-CoV-2 Spike protein provides strong protection against SARS-CoV-2 in mice and golden hamsters by reducing viral load and inflammation.

bioRxiv · Jul 21, 2020 · PreprintImmunology